ACARBOSE
- Product NDC
- 11788-041
- 11-digit product format
- 117880041
- Labeler code
- 11788
- Product ID
- 11788-041_ae9f2dbb-1c10-c5d7-e053-2a95a90a78c0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ACARBOSE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aiping Pharmaceutical
- Application
- ANDA213821
- Marketing category
- ANDA
- Marketing start
- 2020-09-30
- Marketing end
- 0000-00-00
- Substance
- ACARBOSE
- Active strength
- 100 mg/1
- Pharmacologic classes
- alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11788-041-01 | ACARBOSE | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11788-041 | ACARBOSE TABLET [AIPING PHARMACEUTICAL] | 1 | Legacy NDC, 1 package rows | 20200930_c445953d-c20a-4b70-8173-009bffc5777b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 11788-041-01 | 11788004101 | 100 TABLET in 1 BOTTLE (11788-041-01) | 100 tablet | 2020-09-30 | 0000-00-00 | No | No | Current |